| Literature DB >> 24997337 |
Kirti Kumar Tiwari1, Chun Chu1, Xanthi Couroucli1, Bhagavatula Moorthy1, Krithika Lingappan2.
Abstract
Caffeine is used to prevent bronchopulmonary dysplasia (BPD) in premature neonates. Hyperoxia contributes to the development of BPD, inhibits cell proliferation and decreases cell survival. The mechanisms responsible for the protective effect of caffeine in pulmonary oxygen toxicity remain largely unknown. A549 and MLE 12 pulmonary epithelial cells were exposed to hyperoxia or maintained in room air, in the presence of different concentrations (0, 0.05, 0.1 and 1mM) of caffeine. Caffeine had a differential concentration-specific effect on cell cycle progression, oxidative stress and viability, with 1mM concentration being deleterious and 0.05 mM being protective. Reactive oxygen species (ROS) generation during hyperoxia was modulated by caffeine in a similar concentration-specific manner. Caffeine at 1mM, but not at the 0.05 mM concentration decreased the G2 arrest in these cells. Taken together this study shows the novel funding that caffeine has a concentration-specific effect on cell cycle regulation, ROS generation, and cell survival in hyperoxic conditions.Entities:
Keywords: A549; Bronchopulmonary dysplasia; Hyperoxia; MLE 12; Pulmonary epithelial cells
Mesh:
Substances:
Year: 2014 PMID: 24997337 PMCID: PMC4216694 DOI: 10.1016/j.bbrc.2014.06.132
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575